Berlin, Germany

Guido Weickgenannt

This inventor holds 2 USPTO granted patents. Top assignees: Henning Berlin Gmbh & Co., Henning Berlin Gmbh Chemie-Und Pharmawerk. Active years: 1994-1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Guido Weickgenannt. Retrieved from https://idiyas.com/inventor/guido-weickgenannt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.4

ph-index = 2

Forward Citations = 46(Granted Patents)


Company Filing History:


Years Active: 1994-1999

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Guido Weickgenannt: Innovator in Medicinal Formulations

Introduction

Guido Weickgenannt is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of medicinal formulations, particularly in the area of thyroid hormones and oxypurinol. With a total of 2 patents, his work has the potential to enhance drug bioavailability and efficacy.

Latest Patents

Weickgenannt's latest patents include innovative formulations that improve the solubility and bioavailability of active substances. One of his patents focuses on "Stabilized medicaments containing thyroid hormones." Another important patent is for the "Formulation of oxypurinol and/or its alkali and alkaline earth salts." This formulation presents oxypurinol in a non-crystalline form, containing the active substance as a solids dispersion with pharmacologically harmless adjuvants. These advancements allow for more rapid and higher solubility compared to traditional formulations.

Career Highlights

Throughout his career, Weickgenannt has worked with reputable companies such as Henning Berlin GmbH & Co. and Henning Berlin GmbH Chemie-Und Pharmawerk. His experience in these organizations has contributed to his expertise in pharmaceutical innovations and formulations.

Collaborations

Some of his notable coworkers include Wolfgang Lahr and Andrea Friese. Their collaborative efforts have likely played a role in the development of his patented formulations.

Conclusion

Guido Weickgenannt's contributions to medicinal formulations demonstrate his commitment to advancing pharmaceutical science. His innovative patents have the potential to significantly improve drug delivery and effectiveness.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…